Systemic Delivery of Antisense Oligomer in Animal Models and Its Implications for Treating DMD
Page 1 of 1
Systemic Delivery of Antisense Oligomer in Animal Models and Its Implications for Treating DMD
Lu QL, Wu B. Systemic Delivery of Antisense Oligomer in Animal Models and Its Implications for Treating DMD. Methods Mol Biol. 2012;867:393-405.
Similar topics
» Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy
» Cell-penetrating peptides enhance systemic delivery of antisense morpholino oligomers
» Bodywide skipping of exons 45–55 in dystrophic mdx52 mice by systemic antisense delivery
» Plasmonic laser treatment for Morpholino oligomer delivery in antisense applications
» Evaluation of Tris[2-(acryloyloxy)ethyl]isocyanurate Cross-linked Polyethylenimine as Antisense Morpholino Oligomer Delivery Vehicle in Cell Culture and Dystrophic mdx Mice
» Cell-penetrating peptides enhance systemic delivery of antisense morpholino oligomers
» Bodywide skipping of exons 45–55 in dystrophic mdx52 mice by systemic antisense delivery
» Plasmonic laser treatment for Morpholino oligomer delivery in antisense applications
» Evaluation of Tris[2-(acryloyloxy)ethyl]isocyanurate Cross-linked Polyethylenimine as Antisense Morpholino Oligomer Delivery Vehicle in Cell Culture and Dystrophic mdx Mice
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
|
|